| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02124525 | Tobacco Smoking|Oxidative Stress|Inflammation | Drug: N-acetylcysteine | Universidade Estadual de Londrina | Phase 3 | 2013-02-01 | 2014-04-24 |
| NCT02865629 | Depression | Drug: N-acetyl cysteine | University of Cincinnati | | 2016-08-01 | 2017-03-21 |
| NCT01808521 | Purpura, Thrombotic Thrombocytopenic|TTP | Drug: N-Acetylcysteine | Bloodworks (Puget Sound Blood Center)|University of Washington | Early Phase 1 | 2013-05-01 | 2016-10-14 |
| NCT01403506 | Disorder Related to Renal Transplantation | Drug: N-acetyl Cysteine | Shahid Beheshti University of Medical Sciences | Phase 3 | 2011-04-01 | 2011-07-26 |
| NCT00967005 | Gambling|Tobacco Use Disorder | Drug: N Acetyl Cysteine|Other: Sugar Pill | Yale University|National Institute on Drug Abuse (NIDA)|University of Minnesota - Clinical and Translational Science Institute | Phase 2 | 2009-09-01 | 2014-03-10 |
| NCT00998972 | Brain Death|Chronic Renal Insufficiency | Drug: N-acetylcysteine | Institut d'Anesthesiologie des Alpes Maritimes | Phase 3 | 2006-09-01 | 2011-07-09 |
| NCT00532688 | Heart Failure, Congestive|Kidney Failure, Chronic | Drug: N-acetylcysteine | Bayside Health|The Alfred | Phase 2|Phase 3 | 2007-09-01 | 2007-09-19 |
| NCT02505477 | Schizophrenia|Cognitive Deficits|Schizophrenia; Negative Type | Drug: N-acetylcysteine|Other: Treatment as Usual | University of California, Los Angeles | Phase 4 | 2017-02-06 | 2017-02-08 |
| NCT01866644 | Unspecified Complication of Liver Transplant | Drug: N-acetylcysteine|Drug: Saline | Instituto de Investigacion Sanitaria La Fe | Phase 3 | 2011-09-01 | 2015-07-21 |
| NCT00896025 | Acute Liver Failure|Fulminant Hepatic Failure | Drug: N-acetylcysteine | William Lee|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Texas Southwestern Medical Center | Phase 4 | 2008-12-01 | 2014-01-29 |
| NCT00637624 | Carcinoma, Non-Small-Cell Lung|Carcinoma, Small Cell Lung|Mesothelioma | Drug: N-Acetylcysteine|Drug: Placebo | Rijnstate Hospital | | 2008-03-01 | 2011-08-08 |
| NCT02212678 | Parkinson Disease | Drug: N-acetylcysteine capsule | University of Minnesota - Clinical and Translational Science Institute|Parkinson's Disease Society of the United Kingdom | Phase 2 | 2014-09-01 | 2016-02-17 |
| NCT00568087 | Alcoholism | Drug: N-acetylcysteine|Drug: Placebo | Minneapolis Veterans Affairs Medical Center|Minnesota Veterans Medical Research and Education Foundation | Phase 1|Phase 2 | 2007-12-01 | 2013-08-28 |
| NCT00248625 | Acute Liver Failure|Hepatic Encephalopathy | Drug: N-acetylcysteine|Drug: Placebo | University of Pittsburgh|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 | 2000-01-01 | 2016-06-16 |
| NCT01118663 | Acetaminophen Overdose | Drug: Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)|Drug: Acetadote | Cumberland Pharmaceuticals | Phase 3 | 2010-09-01 | 2014-08-01 |
| NCT01726465 | Ischemic Reperfusion Injury|Insufficiency; Hepatic, Postoperative|Liver Tumour | Drug: Methylprednisolone|Drug: N-acetylcysteine | Istituto Clinico Humanitas | Phase 2 | 2012-11-01 | 2013-11-09 |
| NCT02788292 | Adipose Tissue Atrophy|Deformity of Reconstructed Breast|Graft Loss | Drug: Acetylcysteine | Michael Bezuhly|Nova Scotia Health Authority | Phase 4 | 2016-07-01 | 2016-05-27 |
